Researchers from the Indian Institute of Technology Guwahati and Bose Institute Kolkata undertook a study to produce an injectable hydrogel for the treatment of breast cancer. This innovative hydrogel-based therapy delivers anti-cancer drugs directly to tumour sites,

IIT Guwahati's innovative hydrogel offers a breakthrough in cancer treatment, targeting tumours directly and reducing side effects. The development marks a significant advancement in localised cancer therapies.

IIT-G and Bose Institute develop advanced injectable hydrogel for precise cancer treatment, minimizing side effects on healthy cells.

Researchers from IIT Guwahati and Bose Institute Kolkata have developed an innovative injectable hydrogel for localized cancer treatment. This biocompatible hydrogel delivers anti-cancer drugs directly to tumours,

Guwahati: A team of scientists from Indian Institute of Technology (IIT) Guwahati and Bose Institute Kolkata has developed an advanced injectable hydrogel for targeted treatment of breast cancer.

A single injection of the hydrogel, loaded with the chemotherapy drug Doxorubicin, resulted in a Rs 75 per cent reduction in tumour size within 18 days. Crucially, the hydrogel remained localised at the tumour site, steadily releasing the drug over time without causing detectable side effects on other organs,” he said.